IWC
CTXR icon

Integrated Wealth Concepts’s Citius Pharmaceuticals CTXR Stock Holding History

Integrated Wealth Concepts’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605 Buy
+1,000
New +$677 ﹤0.01% 5624

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

Integrated Wealth Concepts's CTXR Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 1,000 shares worth $605. The stake represents ﹤0.01% of the portfolio and ranks #5624 among its holdings.

43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Integrated Wealth Concepts held 1,000 shares of Citius Pharmaceuticals worth $605 as of Q2 2026.
  • Citius Pharmaceuticals was a new Integrated Wealth Concepts position in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5624 holding.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.